Stock listing
Captor Therapeutics Sa
Selected listing: A3CNAX · LS · EUR · DE
Captor Therapeutics Sa (Lang & Schwarz: A3CNAX), Health Technology. Latest release May 30, 2023: Captor Therapeutics Publishes Q1 2023 Financial Results.
- Ticker
- Lang & Schwarz: A3CNAX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Captor Therapeutics Sa
The company focuses on developing innovative therapeutic solutions. Its commitment to advancing healthcare is reflected in its ongoing research and development efforts.
Latest news from Captor Therapeutics Sa
Research Captor Therapeutics Sa
Captor Therapeutics Sa company profile
View the public company page for Captor Therapeutics Sa on 6ix.
Captor Therapeutics Sa news
Read company news and market updates connected to Captor Therapeutics Sa.
Captor Therapeutics Sa investor events
Find investor webinars, events, and replay context for Captor Therapeutics Sa.
Alternate listings
CTX:GPW
PL · PLN
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
60Q:GETTEX
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
A3CNAX:LSX
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
60Q:MUN
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
60Q:FWB
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
60Q:SWB
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.
60Q:DUS
DE · EUR
Alternate listing for Captor Therapeutics Sa; the primary context on this page is A3CNAX:LS.